Michael Celano serves as the Chief Financial Officer and Secretary at LARIMAR THERAPEUTICS INC, a position he has held with distinction. With a robust background in finance and corporate management, Celano brings a wealth of experience to the company. Prior to joining Larimar Therapeutics, he held significant roles at several prominent organizations, including CFO positions at pharmaceutical and biotechnology firms. His career is marked by a strong track record of steering companies through financial complexities and growth phases, making him an invaluable asset to Larimar. At Larimar Therapeutics, Celano is responsible for overseeing the company's financial strategy and operations. His role encompasses managing the financial planning and analysis, accounting, and investor relations functions. Under his leadership, Larimar has seen improved financial stability and transparency, which has been crucial for the company's ongoing research and development efforts. Celano's strategic foresight and meticulous approach to financial management have been instrumental in guiding Larimar through the competitive landscape of the biopharmaceutical industry. Celano's achievements extend beyond his current role at Larimar. He is recognized in the industry for his contributions to financial strategy and corporate governance. His expertise in navigating the intricacies of financial regulations and his ability to foster strong relationships with investors have earned him a reputation as a trusted leader. Celano's dedication to advancing Larimar's mission to develop life-changing therapies is evident in his tireless efforts to ensure the company's financial health and strategic growth.